Next Wednesday’s free webinar from Lachman, “FDA Incentivizing Organizational Maturity to Drive Product Quality,” will be hosted by Lachman’s Vizma Carver, M.S. In this 90-minute session, she will dive in on the FDAs efforts to utilize incentives to drive product quality. As someone who used to work at the FDA, Ms. Carver is uniquely positioned to help consultants and medical device manufacturers better understand and participate in the current incentive programs.

Ms. Carver has more than 25 years of experience directing worldwide teams in developing first-generation healthcare, biotech, and national security solutions. At the FDA, Carver served as a CDRH Entrepreneur-in-Residence and co-led the Medical Device Innovation Consortium Case-for-Quality Maturity Model. She also was named Expert Digital Health Advisor for the FDA’s Digital Health Unit.

From regulatory relief to pilots evaluating mandatory programs, Ms. Carver, a Senior Associate in the Compliance Practice, will explore and explain why the FDA is looking towards organizational excellence as the mechanism to improve patient safety while accelerating approvals. “These voluntary programs are critical in driving the industry forward,” she says. “From regulatory relief to pilots evaluating mandatory programs, the FDA is leveraging organizational excellence as a mechanism to improve patient safety, while accelerating approvals.”

Register today for the webinar and check out the full schedule for next week below.

 

WEDNESDAY, FEBRUARY 3
11AM – 12:30PM EST

How the FDA is Incentivizing
Organizational Maturity to
Drive Product Quality

Learn about FDA programs from one of FDA’s program co-founders

REGISTER HERE

– MONDAY, FEBRUARY 1 –
Using AI to Modernize Diagnostics Tools
Discover the FDA position on AI to modernize diagnostic tools and more

– TUESDAY, FEBRUARY 2 –
Medical Device and Drug
Development and Manufacturing
Data Governance in the Information Age
The pitfalls to implementing Enterprise Resource Planning (ERP) and other topics

– THURSDAY, FEBRUARY 4 –
Don’t Reinvent the Wheel:
Use your SDLC infrastructure to manage product change control
What is really lost when SDLC is seen as a paper exercise and more

– FRIDAY, FEBRUARY 5 –
Cybersecurity as the Offensive to protect your assets Includes understanding the Homeland Security initiative with the FDA